Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tavros Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Tavros Therapeutics

Tavros Therapeutics

Series B

Tavros Therapeutics: A Durham-based biotech firm specializing in precision oncology since 2019.

HQ
Durham, NC, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded in 2019 and based in Durham, North Carolina, Tavros Therapeutics is a biotechnology company focused on precision oncology. Their core mission is to discover and develop targeted therapies for cancer, leveraging advanced scientific research and technology. Tavros offers innovative solutions aimed at enhancing the efficacy of cancer treatments, with a market focus on oncology therapeutics.

Notable affiliations include collaborations with Vividion Therapeutics and OpenBench, which have led to significant milestone achievements in drug discovery. The company has successfully raised substantial funding through an oversubscribed Seed II round, underscoring investor confidence. Tavros Therapeutics' impact lies in its potential to revolutionize cancer treatment through precision medicine, making significant strides in targeted oncology programs.

Tavros Therapeutics - Similar Companies

Tavotek Biotherapeutics logo

Tavotek Biotherapeutics

tavotek.com

Treadwell Therapeutics logo

Treadwell Therapeutics

treadwelltx.com

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

Synnovation Therapeutics logo

Synnovation Therapeutics

synnovationtx.com

Tactiva Therapeutics logo

Tactiva Therapeutics

PineTree Therapeutics logo

PineTree Therapeutics

pinetreetx.com

Scorpion Therapeutics logo

Scorpion Therapeutics

Alterome Therapeutics logo

Alterome Therapeutics

alterome.com

Tango Therapeutics logo

Tango Therapeutics

tangotx.com

OncoPrecision logo

OncoPrecision

oncoprecision.bio

Vivace Therapeutics logo

Vivace Therapeutics

Angarus Therapeutics logo

Angarus Therapeutics

angarustx.com

Tvardi Therapeutics logo

Tvardi Therapeutics

Fore Biotherapeutics logo

Fore Biotherapeutics

fore.bio

Alphina Therapeutics logo

Alphina Therapeutics

Tavros Therapeutics - Quick Facts

Who are Tavros Therapeutics' competitors?

Companies similar to Tavros Therapeutics include Tavotek Biotherapeutics, Treadwell Therapeutics, Nested Therapeutics and Synnovation Therapeutics.

When was Tavros Therapeutics founded?

Tavros Therapeutics was founded in 2019.

Where is Tavros Therapeutics' headquarters located?

Tavros Therapeutics' headquarters is located in Durham, NC, US.

When was Tavros Therapeutics' last funding round?

Tavros Therapeutics' most recent funding round was for $17.5M (USD) in October 2022.

How much has Tavros Therapeutics raised to-date?

As of Oct 12, 2022, Tavros Therapeutics has raised a total of $28M (USD).

How many employees does Tavros Therapeutics have?

Tavros Therapeutics has 17 employees as of Feb 5, 2024.

Tavros Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Oncology Therapeutics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified